Humana Shares Plunge Following Earnings Forecast Slash

US health insurer Humana witnessed a dramatic sell-off in its stock after presenting mixed quarterly results and significantly revising its full-year earnings guidance downward. Although adjusted earnings surpassed market expectations, investors reacted sharply to the reduced GAAP profit outlook, driving the share price down more than 12% within days.

A significant factor behind the negative investor sentiment stems from a legal ruling on October 14, 2025. Humana lost a court dispute concerning its Medicare Advantage Star Ratings for 2025. This legal defeat is projected to have substantial financial repercussions in 2026, including:

• A reduction in the proportion of Medicare members enrolled in highly-rated plans, falling to 20% from a previous 25%.
• An estimated Read more...